Pathstone Family Office, LLC Clovis Oncology, Inc. Transaction History

Pathstone Family Office, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $19,240 - $41,360	-4,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $16,520 - $25,640	4,000 New	4,000 $19,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $1,138 - $1,938	-200 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$3.77 - $11.0 $754 - $2,200	200 New	200 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.